Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
New York Times - Feb 4, 2026
The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.